SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001654954-19-013139
Filing Date
2019-11-18
Accepted
2019-11-18 17:03:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT sc13d-a6.htm SC 13D/A 97447
2 EXHIBIT 99.1 ex991.htm EX-99.1 100863
  Complete submission text file 0001654954-19-013139.txt   200070
Mailing Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2
Business Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2 416-798-3001
Intellipharmaceutics International Inc. (Filed by) CIK: 0001474835 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1130
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2
Business Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2 416-798-3001
Intellipharmaceutics International Inc. (Subject) CIK: 0001474835 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1130
Type: SC 13D/A | Act: 34 | File No.: 005-85064 | Film No.: 191228210
SIC: 2834 Pharmaceutical Preparations